The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

DexCom Inc

Nasdaq: DXCM
Last

(U.S.) $56.25

Today's change0.00 0.00%
Updated February 11 4:00 PM EST. Delayed by at least 15 minutes.
 

DexCom Inc

Nasdaq: DXCM
Last

(U.S.) $56.25

Today's change0.00 0.00%
Updated February 11 4:00 PM EST. Delayed by at least 15 minutes.

DexCom Inc closed at (U.S.)$56.25.

Over the last five days, shares have lost 20.36% and are down 31.32% for the last year to date. This security has performed in-line with the S&P 500 during the last year.

Key company metrics

  • Open(U.S.) $0.00
  • Previous close(U.S.) $56.25
  • High--
  • Low--
  • Bid / Ask-- / --
  • YTD % change-31.32%
  • Volume0
  • Average volume (10-day)1,539,478
  • Average volume (1-month)1,152,386
  • Average volume (3-month)944,454
  • 52-week range(U.S.) $47.92 to (U.S.) $103.29
  • Beta0.52
  • Trailing P/ENegative, not meaningful
  • P/E 1 year forwardNegative, not meaningful
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) -$0.72
Updated February 11 4:00 PM EST. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
-16.26%

Although this company's net profit margin is negative, it is above the industry average and implies that DexCom Inc is operating more effectively than other companies in the industry.
Company Books

S&P TSX0.81%Sector:HealthcareIndustry:Medical Equipment, Supplies & Distribution

Latest Press Releases

View more Press Releases
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q3/2015Q2/2015Q1/2015Q4/2014
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedSep 30, 201509/30/2015Jun 30, 201506/30/2015Mar 31, 201503/31/2015Dec 31, 201412/31/2014
Revenue105937384
Total other revenue--------
Total revenue105937384
Gross profit75664759
Total cost of revenue31272625
Total operating expense148978683
Selling / general / administrative52453936
Research & development65242022
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)--------
Other operating expenses, total--------
Operating income-42-4-132
Interest income (expense), net non-operating0000
Gain (loss) on sale of assets--------
Other--------
Income before tax-43-4-131
Income after tax-43-4-131
Income tax, total------0
Net income-43-4-131
Total adjustments to net income--------
Net income before extra. items-43-4-131
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items-43-4-131
Inc. avail. to common incl. extra. items-43-4-131
Diluted net income-43-4-131
Dilution adjustment------0
Diluted weighted average shares81807877
Diluted EPS excluding extraordinary itemsvalue per share-0.53-0.05-0.170.02
Dividends per sharevalue per share0.000.000.00--
Diluted normalized EPSvalue per share-0.53-0.05-0.170.02